National Cheng Kung Univ Hosp
Tainan 00704
0 studies enrolling now · 7 studies all time
What they study most
Asthma, Carcinoma, Hepatocellular, Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Carcinoma, Solid Tumors
Studies at this site
- A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication — Stopped early
- A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants — Completed
- Screening Study for Participants With Malignant Tumors — Completed
- A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer — Completed
- A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) — Completed
- A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma — Completed
- A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment — Completed